Home Search
gene therapy - search results
If you're not happy with the results, please do another search
The emergence of precision medicine for oncology
Dr Priya Hays, PhD, considers how the rapid development of precision medicine for oncology has impacted diagnosis, treatment, and clinical outcomes in cancer care.
Exploring hexacorallian models to aid corals affected by climate change
In this interview, Benyamin Rosental, PhD, from the Shraga Segal Department of Microbiology, Immunology, and Genetics, looks toward hexacorallian models to transplant stem cells to corals affected by global warming.
Aarno Dietz – Kuopio University Hospital
Professor Aarno Dietz is a specialist in audiology, otoneurology, skull-base and cochlear implant surgery
He currently Clinical Director of the Center of Excellence for Sense Organ Diseases at the Kuopio University Hospital, Finland. He is a member of the EU expert panel on medical devices and leads the ‘Towards better...
Precision medicine: Sensorineural hearing loss treatment
Aarno Dietz, Professor of Otorhinolaryngology at Kuopio University Hospital, turns the spotlight on hospital precision medicine, focusing on the treatment of sensorineural hearing loss.
Honeywell Manufacturing Excellence Platform: driving digital transformation in life sciences
Honeywell's Manufacturing Excellence Platform will revolutionise the digital transformation of the life sciences industry.
Clinical Endpoints and data management in the era of ophthalmic precision medicine
Eric Buckland of Translational Imaging Innovations and Ronald Schuchard, Clinical Product Development Expert, explore the benefits of ophthalmic precision medicine to improve patient care across sectors.
What are the possibilities of DNA and RNA sequences?
Serge L. Beaucage, Supervisory Research Chemist at the Food and Drug Administration discusses his work with DNA and RNA sequences and the groundbreaking impact this technique could have.
COVID-19 impact on rare disease: Peroxisomal disorders
Dr Michael Wangler, Assistant Professor at Molecular and Human Genetics Baylor College of Medicine and Katie Sacra, Director of Family Programs, Global Foundation for Peroxisomal Disorders, mother of TJ, discusses the impact of the COVID-19 pandemic on families with rare disease - especially peroxisomal disorders.
£2.3 million awarded to York University for sickle cell anaemia research
The Bill & Melinda Gates foundation have awarded £2.3million to the University of York, in attempt to push research into sickle cell anaemia.
TUBB4A-associated leukodystrophy
Dr Dan Williams, SynaptixBio CEO, discusses the search to find the first treatment for one of the world’s rarest diseases, TUBB4A-associated leukodystrophy
Neurological disorders: Developing therapies for cats, dogs & patients
Charles H. Vite, DVM, PhD from School of Veterinary Medicine at University of Pennsylvania, focuses on a fascinating aspect of neurological disorders concerning developing therapies for cats, dogs & patients.
Investing in the future of neuroscience
Nina Schor, Deputy Director and Acting Scientific Director of NINDS, underlines the importance of investing in the future of neuroscience.
Harnessing digital innovations to become a beacon of hope for Rett patients
The CIPP Rett Centre provides treatment for emotional, behavioural and autonomic difficulties/disorders in patients with Rett Syndrome.
Huntington’s disease: Present concern & therapeutic view
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, describes the present concern and future therapeutic perspective on Huntington’s disease.
Targeted policy support for emerging biomedical innovations
Michael Morrison, Senior Researcher in Social Science at the University of Oxford, illustrates the importance of emerging biomedical innovations in the UK.
The promises and challenges of biomodifying technologies for the UK
Michael Morrison, Senior Researcher in Social Science at the Centre for Health, Law and Emerging Technologies (HeLEX), University of Oxford, sheds light on the promises as well as biomodifying technologies for the UK.
The mechanisms that govern skeletal muscle function
In this second interview, Professor Dr Martin Flück reveals how his research aims to shed light on the mechanisms that govern skeletal muscle function in health and disease, with the goal of translating the findings into more effective clinical applications.
The role of TXNIP in mitochondrial-lysosomal axis dysregulation
Lalit P. Singh, Associate Professor at Wayne State University School of Medicine, explains the role of TXNIP in mitochondrial-lysosomal axis dysregulation in diabetic retinopathy.
Cancer research in Japan: Basic, clinical and translational
Here, we examine the role of the Japanese Cancer Association (JCA) when it comes to the field of cancer research in Japan, including basic, clinical and translational.
Delivering improved health and wealth in the UK
Jane Kinghorn, Director of the Translational Research Office at UCL, discusses the importance of research and partnership in improving the health and wealth of the UK.